Dianthus Therapeutics, Inc. (DNTH) Capital expenditures 2016–2022
Dianthus Therapeutics, Inc. (DNTH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$314,000FY2022 · since FY2016: $139,000 → $314,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $314,000 | -75.2% |
| FY2021 | $1.3M | +216.0% |
| FY2020 | $400,000 | -86.9% |
| FY2019 | $3.1M | -60.1% |
| FY2018 | $7.7M | +248.9% |
| FY2017 | $2.2M | +1482.0% |
| FY2016 | $139,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice